The different methodological approaches consistently suggest that there is not enough evidence to reject the null hypothesis in the comparison of serum IL-33 levels between nondiabetic individuals with obesity and healthy controls. The gene discussed is IL33; the disease is obesity due to melanocortin 4 receptor deficiency.